Pseudomyxoma peritonei: unusual origin from teratoma associated mucinous cystadenoma of ovary

Authors

  • Manju Pandey Gynaeoncology Unit, Department of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Binuma Shrestha Gynaeoncology Unit, Department of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Bijay Chandra Acharya Gynaeoncology Unit, Department of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Suraj Upreti Department of Pathology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal

DOI:

https://doi.org/10.3126/njc.v5i1.41371

Keywords:

Pseudomyxoma peritonei, Mucinous cystadenoma, Mature cystic teratoma, Appendix

Abstract

Pseudomyxoma peritonei is an extremely rare clinical syndrome with incidence of approximately two per 10000 laparotomies. Approximately 44% of women with PMP have ovarian mucinous tumor. It is generally accepted that the ovarian involvement is secondary; PMP is nearly always gastrointestinal origin, usually from mucinous adenoma of the appendix1. Exception to this, we report a 35 years lady who presented with the complaint of abdominal pain and abdominal distention for two months, clinically and radiologically gross mucinous ascites with large abdominopelvic mass was evident. Final histopathology was reported as mucinous cystadenoma, with mature teratoma components, appendix was normal. 

Downloads

Download data is not yet available.
Abstract
126

Published

2021-09-26

How to Cite

Pandey, M., Shrestha, B., Acharya, B. C., & Upreti, S. (2021). Pseudomyxoma peritonei: unusual origin from teratoma associated mucinous cystadenoma of ovary. Nepalese Journal of Cancer, 5(1), 76–79. https://doi.org/10.3126/njc.v5i1.41371

Issue

Vol. 5 No. 1 (2021)

Section

Case Reports

License

Copyright (c) 2021 Nepalese Journal of Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.

Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.